Multilateral development banks (MDBs) are moving to centre stage in global health financing, driven by collapsing bilateral aid and political momentum from initiatives like the Accra Reset. Experts see the shift as an opportunity to deliver the predictable, large-scale investment needed to strengthen domestic health systems, provided governments and lenders can ensure transparent terms that […] Continue reading ->
WHO has greenlighted Phase 2/3 trials for two brand new vaccine candidates that specifically target the Ebola Bundibugyo virus species ravaging the Democratic Republic of Congo. Actual trials could forseeably commence  “within three to four weeks” – as soon as  DRC regulators issue their own approval,  said WHO’s Science Director Meg Doherty, at a Wednesday […] Continue reading ->
Hanan Balkhy, Saudi Arabia’s candidate for WHO Director General, is especially concerned about antibiotic resistance, the effects of climate change on health, and healthcare in conflict zones. She also warns about a “normalisation” of attacks on hospitals and healthcare workers in conflict regions. As a longtime WHO insider, she is also well aware that the […] Continue reading ->
France’s Ambassador for Global Health, Dr Anne-Claire Amprou, is joining the leadership of the World Health Organization (WHO) body negotiating the missing piece of the Pandemic Agreement at a crucial moment. Amprou co-chaired the last stage of Pandemic Agreement talks, which eventually found consensus. However, consensus has eluded WHO member states on the pathogen access […] Continue reading ->
Cuts to Medicaid, the health services for low-income Americans, and fewer childhood immunisations – alongside persistent insinuations that vaccines are unsafe – are the most significant health policy changes made by the Trump administration since January 2025. They have been accompanied by reduced food support for low-income families, purges of scientists, and slashed research budgets.  […] Continue reading ->